Brief: Crossject delays filing of marketing authorization for Zénéo Adrenaline

Crossject SA

17/06/2016 16:58

June 17 (Reuters) - Crossject SA  ALCJ.PA : 
    * Due to a delay in bioequivalence study led by its customer, filing of marketing 
authorization for Zénéo Adrenaline should be delayed several months as well 
 
Source text for Eikon:  ID:nHUGbfpQV8  
Further company coverage:  ALCJ.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))